Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2005
03/17/2005WO2005003087A3 Oxazole derivatives as antibacterial agents
03/17/2005WO2004106315A3 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
03/17/2005WO2004106294A3 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
03/17/2005WO2004092196A3 Tie-2 modulators and methods of use
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005WO2004072033A3 Pyrazoles and methods of making and using the same
03/17/2005WO2003053959A8 Heterocyclylamino carbonyluracils
03/17/2005WO2003037887A8 Therapeutic isoquinoline compounds
03/17/2005US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
03/17/2005US20050059676 Cyclic pyrazinoylguanidine sodium channel blockers
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059657 Aminoisoxazole derivatives active as kinase inhibitors
03/17/2005DE10306502B4 Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel Substituted 3- (Benzoylureido) -thiophenderivate and medicaments containing them
03/17/2005CA2537883A1 Substituted bicyclic quinazolin-4-ylamine derivatives
03/17/2005CA2537345A1 Intermediates for the preparation of oxazolidinone-quinolone hybrids
03/17/2005CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/16/2005EP1513917A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
03/16/2005EP1513832A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
03/16/2005EP1513829A2 Nicotinoyl derivatives as herbicidal compounds
03/16/2005EP1513817A1 1, 2-azole derivatives with hypoglycemic and hypolipidemic activity
03/16/2005EP1513812A1 Substituted indoles
03/16/2005EP1513530A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1594316A Substituted pyrazolone derivatives and their preparing process and pharmaceutical conpositions
03/16/2005CN1594298A Pyridine ring containing oxazolidinone compounds and preparation process and application thereof
03/16/2005CN1193027C Substituted pyrroles
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867226 Preventing diarrhea
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/15/2005US6867207 IL-5 inhibiting 6-azauracil derivatives
03/15/2005US6867204 Benzoxazine derivatives and uses thereof
03/15/2005US6867200 Anticancer agents; anticoagulants
03/10/2005WO2005021540A1 Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
03/10/2005WO2005021539A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
03/10/2005WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
03/10/2005WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005WO2005021518A1 Condensed ring compound and use thereof
03/10/2005WO2005021516A1 Caspase inhibitors containing isoxazoline ring
03/10/2005WO2005021515A2 Inhibitors of phosphodiesterase type-iv
03/10/2005WO2005021512A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021486A1 Ester derivative and medicinal use thereof
03/10/2005WO2005020999A1 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
03/10/2005WO2005020985A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004096128A3 Hiv integrase inhibitors
03/10/2005WO2004087880A3 Compounds and their use to treat diabetes and related disorders
03/10/2005WO2004071447B1 Substituted azole derivatives as therapeutic agents
03/10/2005US20050054850 E.g., {4-Chloro-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethoxy]phenyl}-(2-methylquinolin-4-yl)amine; congestive heart failure, stroke, antiischemic, -arrhythmia, -arthritis, -diabetic, -inflammatory, -ulcer and hypotensive agents; urogenital, bone, respiratory, cardiovascular and nervous systems disorders
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
03/10/2005US20050054710 Inhibits effect on various receptor tyrosine kinases and CDK (cyclin dependent kinases) complexes and on the proliferation of endothelial cells and various tumor cells
03/10/2005US20050054704 Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
03/10/2005US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes
03/10/2005US20050054683 Microbiocides; bacteriocides; oxazolidinone compound
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054657 Induce immunology response; anticancer agents
03/10/2005US20050054654 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054638 Anticancer agents
03/10/2005US20050054630 Fused bicyclic carboxamide derivatives and methods of their use
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005CA2537185A1 Inhibitors of phosphodiesterase type-iv
03/10/2005CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005CA2537123A1 New compounds
03/10/2005CA2536871A1 Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1511745A2 Protease inhibitors
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1018008B1 Method of identification of leads or active compounds
03/09/2005EP0869792B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
03/09/2005CN1592745A Therapeutic chromone compounds
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1590386A Sidechain-bearing taxanes and method for the preparation thereof
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 647